Text Data Mining
Services from ROP

Research Optimus (ROP) is a leading provider of white-label Pharmaceutical and healthcare data mining services to research firms. We also offer comprehensive text data mining services for research on a new drug possibility or other medical research projects to pharma companies.

Our cost-effective techniques for extracting key pieces of data from major sources, analyzing and presenting it in an organized way have been pivotal in making us the first choice for offshoring for many MNCs, SMEs, startups, and Fortune 5,000 companies.

Our offices are situated in Bangalore, India and we cater to pharma companies and research firms from across North America, Europe, and Australia.

Contact Us

captcha_number

Healthcare Data Mining Services by ROP

ROP offers comprehensive services in the area of text data mining for pharma companies –

  • Biomedical Literature

    We curate information from major biomedical literature including PUBMED Central and Medline Abstracts.

  • Other Medical Sources

    Depending on the type of research being performed and the data needed for your study, we can gather information from other key medical literary sources.

  • Chemical Literature

    We access major publication databases for chemical and biochemical data, such as ACS Publications.

  • Patents

    We can sift through the daunting database of the US Patent and Trademark Office during the early phases of drug testing.

  • Clinical Documents

    We can investigate key sources of clinical trial and research data for important results.


Contact Us

Whatever your text data mining needs are, you can rely on the experts of Research
Optimus to curate, collate and enter that data into a customized database for your
needs. Talk to our ‘analyst on hire’ today to learn more about our full range of healthcare
data mining services available with flexible engagement plans.


Research Optimus

Recent Case Study

Testimonials - What Clients Say

Subscribe Newsletter

Subscribe Newsletter

Get the latest Newsletter from Research Optimus